Literature DB >> 2644246

Crystallization of the aspartylprotease from the human immunodeficiency virus, HIV-1.

B M McKeever1, M A Navia, P M Fitzgerald, J P Springer, C T Leu, J C Heimbach, W K Herbert, I S Sigal, P L Darke.   

Abstract

The aspartylprotease of the human immunodeficiency virus HIV-1 (NY5) has been crystallized in a form suitable for x-ray diffraction analysis. The crystals are tetragonal bipyramids and produce an x-ray diffraction pattern that exhibits the symmetry associated with space group P4(1)2(1)2 (or its enantiomorph, P4(3)2(1)2). The unit cell parameters are a = b = 50.3 A, c = 106.8 A, alpha = beta = gamma = 90 degrees; measurable diffraction intensities are observed to a resolution of 2.5 A. Density measurements indicate one molecule of 9,400 daltons/asymmetric unit. The symmetry of this space group could accommodate the proposed active dimer species of the protease if the 2-fold axis were coincident with one of the crystallographic 2-fold axes.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2644246

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  2 in total

1.  Production of cytotoxic proteins in Escherichia coli: a fermentation process for producing enzymatically active HIV-1 protease.

Authors:  W K Herber; F J Bailey; C E Carty; J C Heimbach; R Z Maigetter
Journal:  Appl Microbiol Biotechnol       Date:  1991-11       Impact factor: 4.813

Review 2.  The early years of retroviral protease crystal structures.

Authors:  Maria Miller
Journal:  Biopolymers       Date:  2010       Impact factor: 2.505

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.